Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series.
Sign Up to like & getrecommendations! Published in 2018 at "Complementary therapies in medicine"
DOI: 10.1016/j.ctim.2018.01.002
Abstract: BACKGROUND Long-term survival of children with cancer has reached rates of up to 80%. Nevertheless, continued research devoted to further improvement of survival rates especially for patients with high-risk illnesses is necessary. Recent studies have… read more here.
Keywords: cancer; high dose; safety high; mistletoe therapy ... See more keywords